Cargando…
On the horizon—the value and promise of the global pipeline of Alzheimer's disease therapeutics
INTRODUCTION: The recent failure of several late‐stage Alzheimer's disease (AD) clinical trials focused on amyloid beta (Aβ) highlights the challenges of finding effective disease‐modifying therapeutics. Despite major advances in our understanding of the genetic risk factors of disease and the...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217086/ https://www.ncbi.nlm.nih.gov/pubmed/32405530 http://dx.doi.org/10.1002/trc2.12009 |